Concepedia

Qingli Wei

QW

Statistics

Publications

6

Citations

297

H-Index

6

Active since

2013

Affiliations

China Pharmaceutical University(Current)

State Key Laboratory of Natural Medicine

Qingli Wei is an author at China Pharmaceutical University specializing in life sciences, biochemistry, and signal transduction.

Publications per year

2013–2019

6

Publications

6

Silybin inhibits NLRP3 inflammasome assembly through the NAD <sup>+</sup> /SIRT2 pathway in mice with nonalcoholic fatty liver disease

Bangling Zhang, Dan Xu, Linlin She et al. · The FASEB Journal · 2017 · 114 citations

, , +17

Silybin ameliorates hepatic lipid accumulation and modulates global metabolism in an NAFLD mouse model

Runbin Sun, Dan Xu, Qingli Wei et al. · Biomedicine & Pharmacotherapy · 2019 · 76 citations · Full text

, , +17

SC-514, a selective inhibitor of IKKβ attenuates RANKL-induced osteoclastogenesis and NF-κB activation

Qian Liu, Huafei Wu, Shek Man Chim et al. · Biochemical Pharmacology · 2013 · 45 citations

, , +15

Curcumin inhibits hepatic stellate cell activation via suppression of succinate-associated HIF-1α induction

Linlin She, Dan Xu, Zixia Wang et al. · Molecular and Cellular Endocrinology · 2018 · 37 citations

, , +12

Curcumin restrains hepatic glucose production by blocking cAMP/PKA signaling and reducing acetyl CoA accumulation in high-fat diet (HFD)-fed mice

Zixia Wang, Dan Xu, Linlin She et al. · Molecular and Cellular Endocrinology · 2018 · 15 citations

, , +15

1–5 of 6